Many studies have proved that inhibiting IGF1R and PI3K/AKT can effectively prevent the malignant biological behavior of ESCC, and improve the treatment sensitivity.51, 52, 53. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.